Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  World Journal of Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00268-016-3691-yPMID 27549595PMCID PMC5800771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases

  2016cited by this paper
• Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma

  2016cited by this paper
• Gallbladder carcinoma: Prognostic factors and therapeutic options.

  2015cited by this paper
• Biliary tract cancers: understudied and poorly understood.

  2015cited by this paper
• Perioperative Management of Hilar Cholangiocarcinoma

  2015cited by this paper
• Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition

  2015cited by this paper
• Patient Perceptions Regarding the Likelihood of Cure After Surgical Resection of Lung and Colorectal Cancer

  2015cited by this paper
• Lymph node status after resection for gallbladder adenocarcinoma: Prognostic implications of different nodal staging/scoring systems

  2015cited by this paper
• Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

  2015cited by this paper
• SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

  2015cited by this paper
• Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience

  2015cited by this paper
• Gallbladder Cancer in the 21st Century

  2015cited by this paper
• Patient perceptions regarding the likelihood of cure after surgical resection of lung and colorectal cancer

  2015cited by this paper
• Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma?

  2015cited by this paper
• Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types

  2014cited by this paper
• S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

  2014cited by this paper
• Multimodal treatment strategies for advanced hilar cholangiocarcinoma

  2014cited by this paper
• Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.

  2014cited by this paper
• What are patients' expectations about the effects of chemotherapy for advanced cancer?

  2014cited by this paper
• Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?

  2013cited by this paper
• Proportion cured models applied to 23 cancer sites in Norway

  2013cited by this paper
• Management of perihilar cholangiocarcinoma in the era of multimodal therapy

  2012cited by this paper
• SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

  2012cited by this paper
• smcure: An R-package for estimating semiparametric mixture cure models

  2012cited by this paper
• Cure Models as a Useful Statistical Tool for Analyzing Survival

  2012cited by this paper
• Surgical strategy for bile duct cancer: Advances and current limitations.

  2011cited by this paper
• Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21

  2011cited by this paper
• Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.

  2011cited by this paper
• Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

  2010cited by this paper
• Evolution of cancer survival analysis.

  2010cited by this paper
• Cure models for estimating hospital-based breast cancer survival.

  2010cited by this paper
• Evolving Treatment Strategies for Gallbladder Cancer

  2009cited by this paper
• Estimating and modeling the cure fraction in population-based cancer survival analysis.

  2007cited by this paper
• Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey

  2004cited by this paper
• Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma

  2003cited by this paper
• Estimating Cure Rates From Survival Data

  2003cited by this paper
• Identification of novel cellular targets in biliary tract cancers using global gene expression technology.

  2003cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma

  2001cited by this paper
• Mixture models for cancer survival analysis: application to population-based data with covariates.

  1999cited by this paper

• Cure after surgery for hepato-pancreato-biliary cancers: A systematic review.

  2024cites this paper
• Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?

  2023cites this paper
• Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814)

  2023cites this paper
• Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.

  2022cites this paper
• Conditional Recurrence-Free Survival for Patients with Gallbladder Cancer: A Personalized Resource for Patients and Providers

  2021cites this paper
• Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs

  2021cites this paper
• Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes

  2021cites this paper
• Surgeon Strategies to Patient-Centered Decision-making in Cancer Care: Validation and Applications of a Conceptual Model

  2021cites this paper
• Laparoscopic Liver Resection for Intrahepatic Cholangiocarcinoma: A Single-Center Experience

  2020cites this paper
• Liver and Bile Duct Cancer

  2020cites this paper
• Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections

  2020cites this paper
• A review of systemic therapy in biliary tract carcinoma.

  2020cites this paper
• Assessing prognosis in cholangiocarcinoma: a review of promising genetic markers and imaging approaches

  2020cites this paper
• Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.

  2019cites this paper
• Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?

  2018cites this paper
• Surgical Management of Hilar Cholangiocarcinoma

  2018cites this paper
• Systematic review of management of incidental gallbladder cancer after cholecystectomy

  2018cites this paper
• Perioperative and Long-Term Outcomes of Laparoscopic Versus Open Lymphadenectomy for Biliary Tumors: A Propensity-Score-Based, Case-Matched Analysis

  2018cites this paper
• Prognosis and Adherence with the National Comprehensive Cancer Network Guidelines of Patients with Biliary Tract Cancers: an Analysis of the National Cancer Database

  2018cites this paper
• Gallbladder cancer: a journey of a thousand steps.

  2018cites this paper
• Neuroendocrine liver metastasis: The chance to be cured after liver surgery

  2017cites this paper
• Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma

  2017cites this paper